Related Experiment Video
Updated: Nov 9, 2025

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing
Mitchell L Leibowitz1,2,3, Stamatis Papathanasiou2,3, Phillip A Doerfler4
1Howard Hughes Medical Institute, Chevy Chase, MD, USA.
Abstract:
Genome editing has therapeutic potential for treating genetic diseases and cancer. However, the currently most practicable approaches rely on the generation of DNA double-strand breaks (DSBs), which can give rise to a poorly characterized spectrum of chromosome structural abnormalities. Here, using model cells and single-cell whole-genome sequencing, as well as by editing at a clinically relevant locus in clinically relevant cells, we show that CRISPR-Cas9 editing generates structural defects of the nucleus, micronuclei and chromosome bridges, which initiate a mutational process called chromothripsis. Chromothripsis is extensive chromosome rearrangement restricted to one or a few chromosomes that can cause human congenital disease and cancer. These results demonstrate that chromothripsis is a previously unappreciated on-target consequence of CRISPR-Cas9-generated DSBs. As genome editing is implemented in the clinic, the potential for extensive chromosomal rearrangements should be considered and monitored.
Insights
CRISPR-Cas9 genome editing can cause dangerous DNA double-strand breaks, leading to chromothripsis, a major cause of cancer and congenital diseases. This study reveals chromothripsis as an unappreciated on-target risk of CRISPR-Cas9 editing that requires clinical monitoring.
Area of Science:
- Molecular Biology
- Genetics
- Genomics
Background:
- Genome editing holds promise for treating genetic diseases and cancer.
- Current methods often induce DNA double-strand breaks (DSBs), potentially causing chromosomal abnormalities.
Purpose of the Study:
- To investigate the chromosomal consequences of CRISPR-Cas9 genome editing.
- To identify if CRISPR-Cas9-induced DSBs lead to chromothripsis.
Main Methods:
- Utilized model cells and single-cell whole-genome sequencing.
- Performed editing at a clinically relevant locus in relevant cells.
Main Results:
- CRISPR-Cas9 editing induced nuclear structural defects, micronuclei, and chromosome bridges.
- These defects initiated chromothripsis, a process of extensive chromosomal rearrangement.
- Chromothripsis was identified as an on-target consequence of CRISPR-Cas9-generated DSBs.
Conclusions:
- Chromothripsis is a previously unrecognized on-target outcome of CRISPR-Cas9 editing.
- The potential for chromosomal rearrangements must be considered and monitored during clinical genome editing applications.
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
Homologous Recombination
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

